Core Scientific Inc. (CORZ) Revenue-to-Profit Sankey Flow & SEC XBRL Financials
Core Scientific Inc. (CORZ) receives a Roarable Rating of D (Sell) and flashes a Red SELL / AVOID warning (51/100 RQD Confidence). Our SEC filing scanner spotted paper earnings outpacing real operating cash flow (-140.1% (NI vs OCF)) while unpaid customer invoices grew—a classic sign to step aside until cash flow catches up.
How CORZ Turns Every Dollar of Sales Into Real Bottom-Line Profit
Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory
| Fiscal Year | Revenue | Gross Margin | Op Margin | Net Profit | Free Cash Flow | ROIC % |
|---|---|---|---|---|---|---|
| FY 2025 | $319.0M | 11.9% | -77% | -$288.6M | -$450.8M | -45% |
| FY 2024 | $510.7M | 23.7% | -27.8% | -$1.44B | -$52.1M | -45% |
| FY 2023 | $502.4M | 44% | 1.8% | -$246.5M | $42.5M | 0.5% |
Red-Light Warning Desk: How Pros Profit When Overhyped Stocks Crack (Featuring CORZ)
- ✓Live walkthrough of CORZ's RQD Radar, SEC cash-conversion gap & downside levels
- ✓3 asymmetric Bear/Hedge setups institutions use when 10-year yields stay elevated
- ✓Includes instant 24/7 email alert whenever any of your stocks flip to Red
CORZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -37.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on CORZ today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for CORZ. Explore sector supply chains on /butterfly.
CORZ Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDHow profitable is Core Scientific Inc. (CORZ)?
In FY 2025 (10-K), CORZ converted $319.0M of revenue into a 11.9% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).